Fig. 6
From: MF-094 nanodelivery inhibits oral squamous cell carcinoma by targeting USP30
NPs enhance the anticancer effects of MF-094 in HSC4 cells. A CLSM images (scale bars: 50 μm). B TEM images showing intracellular distribution of MF-094@NPs in HSC4 cells (scale bars: 4 μm). C Cell viability, D and E apoptosis, F glutamine consumption, and G expression of c-Myc, GLS1, and SLC1A5 in HSC4 cells incubated with MF-094, NPs, and MF-094@NPs. *P < 0.05, **P < 0.01, ***P < 0.001